Ophthalmic drug delivery device
US6669950B2 · kind B2 · utility
107Cited by
44References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 1, 2002 |
| Grant date | Dec 30, 2003 |
| Priority date | — |
| Expiry date | Jul 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F9/00781
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a drug delivery device for a human eye. The human eye has a sclera, an inferior oblique muscle, and a macula. The device of the present invention includes a pharmaceutically active agent, and a geometry that facilitates the implantation of the device on an outer surface of the sclera, beneath the inferior oblique muscle, and with the pharmaceutically active agent disposed above the macula. Methods of delivery a pharmaceutically active agent to the posterior segment of the human eye are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.